Evidence map›Paper›PMID 42467065›Full record

ArticleAntimicrobial agents and chemotherapy2026

Insights into amoxicillin pharmacokinetics using physiology-based pharmacokinetic modelling.

Christopher A Darlow, Vineet Dubey, Nada Reza, William Hope

Abstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Christopher A DarlowAntimicrobial Pharmacodynamics and Therapeutics, University of Liverpool, Liverpool, United Kingdom.ORCID 0000-0002-5400-3413
Vineet DubeyAntimicrobial Pharmacodynamics and Therapeutics, University of Liverpool, Liverpool, United Kingdom.ORCID 0000-0003-3793-1469
Nada RezaAntimicrobial Pharmacodynamics and Therapeutics, University of Liverpool, Liverpool, United Kingdom.ORCID 0000-0003-1183-3262
William HopeAntimicrobial Pharmacodynamics and Therapeutics, University of Liverpool, Liverpool, United Kingdom.ORCID 0000-0001-6187-878X

Funding

Medical Research Council MR/Z505018/1National Institute for Health and Care Research CL-2022-07-001Wellcome TrustWellcome Trust 226691/Z/22/Z
6 · The paper itself

Abstract

Amoxicillin is the most commonly used antibiotic globally. However, there is a relatively poor understanding of its pharmacokinetics, pharmacodynamics, and clinical pharmacology. We constructed a physiology-based pharmacokinetic (PBPK) model of amoxicillin to gain deeper insights into the adequacy of amoxicillin regimens for the treatment of infections relevant to global health. We constructed an amoxicillin PBPK model in PK-Sim using known ADME and physicochemical parameters,

Indexed as

AmoxicillinAnti-Bacterial AgentsHaemophilus influenzaeHumansMicrobial Sensitivity TestsModels, BiologicalOrganic Anion Transporters, Sodium-IndependentStreptococcus pneumoniaeAmoxicillinAnti-Bacterial AgentsOrganic Anion Transporters, Sodium-Independentorganic anion transport protein 3amoxicillinHaemophilus influenzaepharmacokineticsphysiology-based pharmacokinetic modelingPK/PDprobenecidStreptococcus pneumoniaeurinary pharmacokinetics

Identifiers

PMID42467065
PMCPMC13436355

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.